Biosimilar Firms Say Irish Price Deal Hinders Uptake, As Govt Plans New Policy Measures

 
• By Ian Schofield
  
Reducing costs
Ireland is banking on biosimilars to reduce drug costs

More from Biosimilars

More from Biosimilars & Generics